These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 3331675)

  • 1. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of N-nitrosopiperidine to mutagens: role of hepatic cytochrome P-450 proteins and contribution of cytosolic fraction.
    Ayrton AD; Smith JN; Ioannides C
    Carcinogenesis; 1987 Nov; 8(11):1691-5. PubMed ID: 3664960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The food pyrolysis product IQ enhances its own activation.
    Ayrton AD; Williams EJ; Rodrigues AD; Ioannides C; Walker R
    Mutagenesis; 1989 May; 4(3):205-7. PubMed ID: 2659938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
    Alldrick AJ; Rowland IR
    Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.
    Ayrton AD; Neville S; Ioannides C
    Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidine.
    Smith JN; Ioannides C
    Mutagenesis; 1987 May; 2(3):205-9. PubMed ID: 3325744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Sadrieh N; Snyderwine EG
    Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
    Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cytosolic oxygenase activity involved in the bioactivation of 2-aminofluorene.
    Leist M; Ayrton AD; Ioannides C
    Toxicology; 1992; 71(1-2):7-20. PubMed ID: 1729770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enzyme inducers on the metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the rat.
    Vavrek MT; Sidoti P; Reinhardt J; Weisburger JH
    Cancer Lett; 1989 Dec; 48(3):183-8. PubMed ID: 2605567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C
    Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
    Edenharder R; Rauscher R; Platt KL
    Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
    Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
    Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and detoxification of dinitropyrenes by cytosol and microsomes from Aroclor-pretreated rats in the Ames and umu assays.
    Shane BS; Winston GW
    Environ Mol Mutagen; 1997; 30(3):303-11. PubMed ID: 9366909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver.
    Shimada T; Okuda Y
    Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The substrate specificity of the rat hepatic cytosolic arylamine oxidase catalyzing the bioactivation of aromatic amines.
    Marczylo T; Ioannides C
    Cancer Lett; 1998 May; 127(1-2):141-6. PubMed ID: 9619870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivation of 6-aminochrysene by animal and human hepatic preparations: contributions of microsomal and cytosolic enzyme systems.
    Marczylo T; Ioannides C
    Mutagenesis; 1994 May; 9(3):233-9. PubMed ID: 7934963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mutagenic potency of several polycyclic aromatic hydrocarbons induced by liver postmitochondrial fractions from control and xenobiotic-treated immature carp.
    Protić-Sabljić M; Kurelec B
    Mutat Res; 1983 Aug; 118(3):177-89. PubMed ID: 6348528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.